© 2021 IEEE. Personal use of this material is permitted. Permissíon from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertisíng or promotional purposes, creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.[EN] This brief is focused on the closed-loop control of postprandial glucose levels of patients with type 1 diabetes mellitus after unannounced meals, which is still a major challenge toward a fully autonomous artificial pancreas. The main limitations are the delays introduced by the subcutaneous insulin pharmacokinetics and the glucose sensor, which typically lea...
In patients with diabetes mellitus type 1, the pancreatic insulin production ceases, causing raise i...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Artificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous gl...
The integration of subcutaneous sensing and insulin delivery technologies with novel control strateg...
This paper addresses the design of blood glucose control during the postprandial period for Type 1 d...
Background: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pa...
Keeping the blood glucose levels within the safe range during meals and exercise still represents a ...
Type 1 diabetes mellitus is the more severe form of diabetes mellitus. It results from a cellular-me...
Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart i...
In patients with diabetes mellitus type 1, the pancreatic insulin production ceases, causing raise i...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
The artificial pancreas (AP) system is designed to regulate blood glucose in subjects with type 1 di...
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin p...
Background: Either under standard basal-bolus treatment or hybrid closed-loop control, subjects with...
Current glucose control systems automatically regulate basal insulin infusion, but users still need ...
Artificial Pancreas (AP) systems consist on a subcutaneous insulin pump connected to a continuous gl...
The integration of subcutaneous sensing and insulin delivery technologies with novel control strateg...
This paper addresses the design of blood glucose control during the postprandial period for Type 1 d...
Background: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pa...
Keeping the blood glucose levels within the safe range during meals and exercise still represents a ...
Type 1 diabetes mellitus is the more severe form of diabetes mellitus. It results from a cellular-me...
Artificial pancreas (AP) systems for people with type 1 diabetes (T1DM) combine the use of a smart i...
In patients with diabetes mellitus type 1, the pancreatic insulin production ceases, causing raise i...
Blood glucose management systems are an important class of Medical Cyber-Physical Systems that provi...
Maintaining good glycemic control is a continuous challenge for type-1 diabetic patients. The curren...